Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2026-02-11 @ 3:09 PM
Study NCT ID:
NCT04426669
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-01-17
First Post:
2020-06-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Sponsor:
Intima Bioscience, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastrointestinal Epithelial Cancer | View |
| None | Gastrointestinal Neoplasms | View |
| None | Cancer of Gastrointestinal Tract | View |
| None | Cancer, Gastrointestinal | View |
| None | Gastrointestinal Cancer | View |
| None | Colo-rectal Cancer | View |
| None | Pancreatic Cancer | View |
| None | Gall Bladder Cancer | View |
| None | Colon Cancer | View |
| None | Esophageal Cancer | View |
| None | Stomach Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Adoptive Cell Therapy, Immunotherapy, Gene Therapy, CISH checkpoint, CRISPR | View |